Boston Scientific Corporation (BSX) vs Cigna Corporation (CI)
CI leads on 10 of 16 compared metrics.
A side-by-side comparison of Boston Scientific Corporation and Cigna Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of June 17, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).
Total return — BSX vs CI
growth of $100 · last 30yBSX +372.2%CI +2236.0%CI compounded faster
BSX CI
BSX vs CI: by the numbers
- •CI is the larger company ($77.02B vs $69.74B market cap).
- •CI trades at the lower earnings multiple (12.46 vs 19.71 P/E).
- •BSX converts more revenue to profit (17.24% vs 2.26% net margin).
- •BSX grew revenue faster over the past five years (15.29% vs 11.28% CAGR).
- •CI pays a dividend (2.09% yield) while BSX does not currently pay one.
Which is better, BSX or CI?
Metric tally: BSX 6 · CI 10It depends on what you're optimizing for:
ValueCI(lower P/E)
GrowthBSX(faster 5Y revenue CAGR)
QualityBSX(higher ROIC)
Metrics side by side
Valuation
| Metric | BSX | CI |
|---|---|---|
| P/E ratio | 19.71 | 12.46● |
| Forward P/E | 12.60 | 8.79● |
| P/S ratio | 3.40 | 0.28● |
| P/B ratio | 2.71 | 1.84● |
| PEG ratio | 0.88 | 0.15● |
| EV / EBITDA | 14.07 | 8.32● |
| FCF yield | 4.91% | 9.86%● |
Profitability
| Metric | BSX | CI |
|---|---|---|
| Gross margin | 70.41%● | 9.30% |
| Operating margin | 20.12%● | 3.42% |
| Net margin | 17.24%● | 2.26% |
| ROE | 13.74% | 14.90%● |
| ROIC | 8.78%● | 7.35% |
Dividends
| Metric | BSX | CI |
|---|---|---|
| Dividend yield | — | 2.09% |
| Payout ratio | — | 27.53% |
Growth (annualized)
| Metric | BSX | CI |
|---|---|---|
| Revenue CAGR (5Y) | 15.29%● | 11.28% |
| EPS CAGR (5Y) | -8.67% | -0.76%● |
| FCF CAGR (5Y) | 19.89%● | -2.03% |
| Total return CAGR (5Y) | 1.86% | 6.13%● |
Frequently asked
- Which is better, BSX or CI?
- It depends on your goal. value: CI (lower P/E); growth: BSX (faster 5Y revenue CAGR); quality: BSX (higher ROIC). Across all compared metrics, CI leads 10 to 6.
- Is BSX or CI cheaper?
- On trailing earnings, CI is cheaper: BSX trades at a 19.71 P/E and CI at 12.46.
- Which has grown faster, BSX or CI?
- Over the past five years, BSX grew revenue faster — BSX at a 15.29% CAGR versus CI at 11.28%.
- Does BSX or CI pay a bigger dividend?
- CI pays a dividend (2.09% yield) while BSX does not currently pay one.
- Is BSX or CI more profitable?
- BSX runs the higher net margin — BSX at 17.24% versus CI at 2.26%.
- Which has been the better investment, BSX or CI?
- Over the past 10-year, CI delivered the higher annualized total return — BSX at 7.47% versus CI at 9.61%. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Boston Scientific P/E ratioCigna P/E ratioBoston Scientific dividend yieldCigna dividend yieldBoston Scientific ROECigna ROEBoston Scientific operating marginCigna operating marginBoston Scientific revenue growthCigna revenue growthBoston Scientific free cash flowCigna free cash flow
Boston Scientific & Cigna appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified June 17, 2026.